Heparin derivatives having decreased anti-Xa specificity

Details Heparin derivatives having decreased anti-Xa specificity Heparin derivatives having decreased anti-Xa specificity

1986-08-20

1988-05-17

Rollins, John

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514822, 536 21, A61K 31725, C08B 3710

Patent

active

047451084

ABSTRACT:
Ester derivatives of heparin are disclosed. These derivatives exhibit low anti-Xa activity in relation to global anticlotting activity.

REFERENCES:
patent: 3835112 (1971-06-01), Mardiguian
patent: 4331697 (1982-03-01), Kudo et al.
patent: 4440926 (1984-04-01), Mardiguian
L. O. Andersson, Thrombosis Research, vol. 9, 1976, pp. 575-583.

Affiliated with

Also associated with

Rating

Heparin derivatives having decreased anti-Xa specificity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heparin derivatives having decreased anti-Xa specificity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin derivatives having decreased anti-Xa specificity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1881489